fol-005
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2016 (NCT02793557)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fol-005
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03467412 | Phase 2 | Mar 5, 2018 | Bioskin GmbH, Follicum AB |
| NCT02793557 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2016 | Follicum AB |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Follicum AB | For profit | 2 | 2 | 1 | 2016 |
| Bioskin GmbH | For profit | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1